Clinical Trial Update: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

This document provides a Phase 2 multiple-dose trial update for AVD-104 in geographic atrophy secondary to age-related macular degeneration, with the study curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• AVD-104

Snippet

Sponsor: Aviceda Therapeutics, Inc. | Conditions: Geographic Atrophy of the Macula, Macular Degeneration | Phase 2 | Status: ACTIVE_NOT_RECRUITING